Global Oncology Academy

Improving CRC Screening Uptake: An Integrated Approach
Improving CRC Screening Uptake: An Integrated Approach
Clinician's Roundtable
Improving CRC Screening Uptake: An Integrated Approach
- Mallik Greene, PhD
Retifanlimab Across POD1UM-303 Subgroups in Squamous Cell Carcinoma of the Anal Canal
Retifanlimab Across POD1UM-303 Subgroups in Squamous Cell Carcinoma of the Anal Canal
Project Oncology®
Retifanlimab Across POD1UM-303 Subgroups in Squamous Cell Carcinoma of the Anal Canal
- Charles Turck, PharmD, BCPS, BCCCP
- Marwan G. Fakih, MD
Closing Gaps in CRC Screening: Patient-Centered Strategies
Closing Gaps in CRC Screening: Patient-Centered Strategies
On the Frontlines of Colorectal Cancer
Closing Gaps in CRC Screening: Patient-Centered Strategies
- Peter Buch, MD, FACG, AGAF, FACP
ESTI Refines Pulmonary Nodule Management in Lung Cancer Screening
ESTI Refines Pulmonary Nodule Management in Lung Cancer Screening
Project Oncology®
ESTI Refines Pulmonary Nodule Management in Lung Cancer Screening
Concurrent Atezolizumab Fails to Improve Survival in Limited-Stage SCLC
Concurrent Atezolizumab Fails to Improve Survival in Limited-Stage SCLC
Project Oncology®
Concurrent Atezolizumab Fails to Improve Survival in Limited-Stage SCLC
Venetoclax and Palbociclib in AML: Exploring New Findings
Venetoclax and Palbociclib in AML: Exploring New Findings
On the Frontlines of AML/ALL
Venetoclax and Palbociclib in AML: Exploring New Findings
- Ryan Quigley
- Jeffrey Tyner, PhD
- Melissa Stewart, PhD
Chairperson’s Perspective: Evidence-Informed Clinical Decision-Making in HER2-Overexpressed and TROP2-Targeted NSCLC
Chairperson’s Perspective: Evidence-Informed Clinical Decision-Making in HER2-Overexpressed and TROP2-Targeted NSCLC
CME/CE
Chairperson’s Perspective: Evidence-Informed Clinical Decision-Making in HER2-Overexpressed and TROP2-Targeted NSCLC
0.25 credits
- Benjamin Levy, MD
0.25 credits
Decoding Co-Mutations in HR+, HER2- Metastatic Breast Cancer
Decoding Co-Mutations in HR+, HER2- Metastatic Breast Cancer
On the Frontlines of Metastatic Breast Cancer
Decoding Co-Mutations in HR+, HER2- Metastatic Breast Cancer
- Abirami Sivapiragasam

Medical News

Medical News
CD3 T-Cell Engagers in Solid Tumours: Engineering, Resistance, and Translational Platforms
03/30/2026
Read more
Medical News
Microglial Fructose Metabolism and Immune Suppression in Glioblastoma
03/19/2026
Read more
Medical News
Clinical AI in Radiology: Translational Tools, Deployment, and Workflow Themes
03/16/2026
Read more
Medical News
Gut Microbiome and Checkpoint Immunotherapy: Reporting Recent Synthesis
03/11/2026
Read more

See more news

CME/CE

Addressing Unmet Needs in Metastatic Uveal Melanoma
Addressing Unmet Needs in Metastatic Uveal Melanoma
CME/CE
Addressing Unmet Needs in Metastatic Uveal Melanoma
1.00 credit
- Marlana Orloff, MD
- Gregory Daniels, MD, PhD
- Jesse Keller, MD
1.00 credit
Patients First: Navigating Asparaginase-Based Treatment in Young Adults With ALL
Patients First: Navigating Asparaginase-Based Treatment in Young Adults With ALL
CME/CE
Patients First: Navigating Asparaginase-Based Treatment in Young Adults With ALL
1.00 credit
- Ryan D. Cassaday, MD
- Daniel J. DeAngelo, MD, PhD
1.00 credit
Patient Perspective: Navigating TGCT Treatment—Surgery vs Systemic Therapy
Patient Perspective: Navigating TGCT Treatment—Surgery vs Systemic Therapy
MinuteCE®
Patient Perspective: Navigating TGCT Treatment—Surgery vs Systemic Therapy
1.00 program credit
- A.J. Gelderblom, MD, PhD
1.00 program credit
The Tumor That’s Not So Tiny: Understanding the Impact of TGCT
The Tumor That’s Not So Tiny: Understanding the Impact of TGCT
MinuteCE®
The Tumor That’s Not So Tiny: Understanding the Impact of TGCT
1.00 program credit
- A.J. Gelderblom, MD, PhD
1.00 program credit

Clinical Practice

Evolving Approaches to Early-Onset CRC Detection
Evolving Approaches to Early-Onset CRC Detection
On the Frontlines of Colorectal Cancer
Evolving Approaches to Early-Onset CRC Detection
- Peter Buch, MD, FACG, AGAF, FACP
Updates in AML Care: Evolving ASH Guidelines for Older Adults
Updates in AML Care: Evolving ASH Guidelines for Older Adults
On the Frontlines of AML/ALL
Updates in AML Care: Evolving ASH Guidelines for Older Adults
- Shelina Ramnarine, PhD
- Mikkael A. Sekeres, MD, MS
Advancing Relapse Prediction in Pediatric AML Through Genomic MRD
Advancing Relapse Prediction in Pediatric AML Through Genomic MRD
On the Frontlines of AML/ALL
Advancing Relapse Prediction in Pediatric AML Through Genomic MRD
- Ryan Quigley
- Amanda Winters, MD, PhD
Neighborhood Archetypes and Patient Outcomes in Pediatric ALL and AML
Neighborhood Archetypes and Patient Outcomes in Pediatric ALL and AML
On the Frontlines of AML/ALL
Neighborhood Archetypes and Patient Outcomes in Pediatric ALL and AML
- Charles Turck, PharmD, BCPS, BCCCP
- Lena Winestone, MD, MSHP

Programs

Are E-Cigarettes Safer? A Closer Look at Lung Cancer Risk
Are E-Cigarettes Safer? A Closer Look at Lung Cancer Risk
AudioAbstracts
Are E-Cigarettes Safer? A Closer Look at Lung Cancer Risk
- Ryan Quigley
How Early Decisions in Upper GI Cancer Shape Long-Term Outcomes
How Early Decisions in Upper GI Cancer Shape Long-Term Outcomes
Project Oncology®
How Early Decisions in Upper GI Cancer Shape Long-Term Outcomes
- Alexandria May, PharmD, BCPS
- Sunnie Kim, MD
Why Molecular Testing Matters in Non-Small Cell Lung Cancer
Why Molecular Testing Matters in Non-Small Cell Lung Cancer
Project Oncology®
Why Molecular Testing Matters in Non-Small Cell Lung Cancer
- Geoffrey Oxnard, MD
Integrating Molecular Testing into NSCLC Care
Integrating Molecular Testing into NSCLC Care
Project Oncology®
Integrating Molecular Testing into NSCLC Care
- Geoffrey Oxnard, MD